-
公开(公告)号：US20090275522A1
公开(公告)日：2009-11-05
申请号：US12223654
申请日：2007-02-05
摘要： The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
摘要翻译： 本发明涉及新化合物，包含该化合物的药物组合物，所述化合物在制备用于治疗特别是休克条件的药物中的用途以及治疗所述病症的方法，其中所述化合物被给药。 化合物由通式（I）表示，如说明书中进一步定义的。
-
公开(公告)号：US20120196808A1
公开(公告)日：2012-08-02
申请号：US13409976
申请日：2012-03-01
申请人： Kazimierz Wisniewski , Claudio Schteingart , Regent LaPorte , Robert Felix Galyean , Pierre Riviere
发明人： Kazimierz Wisniewski , Claudio Schteingart , Regent LaPorte , Robert Felix Galyean , Pierre Riviere
摘要： The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
摘要翻译： 本申请涉及新化合物，包含其的药物组合物，所述化合物在制备用于治疗特别是休克条件的药物中的用途以及治疗所述病症的方法，其中施用所述化合物。 化合物由通式（I）表示，如说明书中进一步定义的。
-
公开(公告)号：US08148319B2
公开(公告)日：2012-04-03
申请号：US11659215
申请日：2005-08-03
申请人： Kazimierz Wisniewski , Claudio Schteingart , Regent Laporte , Robert Felix Galyean , Pierre Riviere
发明人： Kazimierz Wisniewski , Claudio Schteingart , Regent Laporte , Robert Felix Galyean , Pierre Riviere
IPC分类号： A61K38/12
摘要： The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
摘要翻译： 本发明涉及新化合物，包含该化合物的药物组合物，所述化合物在制备用于治疗特别是休克条件的药物中的用途以及治疗所述病症的方法，其中所述化合物被给药。 化合物由通式（I）表示，如说明书中进一步定义的。
-
公开(公告)号：US08883965B2
公开(公告)日：2014-11-11
申请号：US12223654
申请日：2007-02-05
摘要： The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
摘要翻译： 本发明涉及新化合物，包含该化合物的药物组合物，所述化合物在制备用于治疗特别是休克条件的药物中的用途以及治疗所述病症的方法，其中所述化合物被给药。 化合物由通式（I）表示，如说明书中进一步定义的。
-
公开(公告)号：US08778881B2
公开(公告)日：2014-07-15
申请号：US13409976
申请日：2012-03-01
申请人： Kazimierz Wisniewski , Claudio Schteingart , Regent LaPorte , Robert Felix Galyean , Pierre J.M. Riviere
发明人： Kazimierz Wisniewski , Claudio Schteingart , Regent LaPorte , Robert Felix Galyean , Pierre J.M. Riviere
摘要： The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
摘要翻译： 本申请涉及新化合物，包含其的药物组合物，所述化合物在制备用于治疗特别是休克条件的药物中的用途以及治疗所述病症的方法，其中施用所述化合物。 化合物由通式（I）表示，如说明书中进一步定义的。
-
公开(公告)号：US20090054309A1
公开(公告)日：2009-02-26
申请号：US11659215
申请日：2005-08-03
申请人： Kazimierz Wisniewski , Claudio Schteingart , Regent Laporte , Robert Felix Galyean , Pierre Riviere
发明人： Kazimierz Wisniewski , Claudio Schteingart , Regent Laporte , Robert Felix Galyean , Pierre Riviere
摘要： The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
摘要翻译： 本发明涉及新化合物，包含该化合物的药物组合物，所述化合物在制备用于治疗特别是休克条件的药物中的用途以及治疗所述病症的方法，其中所述化合物被给药。 化合物由通式（I）表示，如说明书中进一步定义的。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.022 秒)
